Corporate News     04-Aug-21
Alkem Laboratories launches Ibuprofen and Famotidine Tablets in US market
Alkem Laboratories (Alkem) today announced the launch of Ibuprofen and Famotidine Tablets (800 mg/26.6 mg) in the United States, following an approval from the United States Food and Drug Administration (US FDA).

Ibuprofen and Famotidine Tablets is AB-rated generic therapeutic equivalent version of Horizon Medicines LLC's Duexis® Tablets, 800 mg/26.6 mg. This is the first generic approval of Duexis® Tablets, 800 mg/26.6 mg by the US FDA. The launch is a subject of ongoing litigation.

Previous News
  Alkem Laboratories fixes record date for interim dividend
 ( Market Beat - Reports 09-Feb-24   16:47 )
  Alkem Laboratories
 ( Results - Analysis 30-May-24   10:39 )
  Alkem Laboratories Ltd gains for third straight session
 ( Hot Pursuit - 07-Dec-23   13:05 )
  Alkem Laboratories to convene AGM
 ( Corporate News - 28-Jun-24   19:25 )
  Alkem Laboratories fixes record date for final dividend
 ( Market Beat - Reports 29-May-24   14:10 )
  Board of Alkem Laboratories recommends Interim Dividend
 ( Corporate News - 09-Feb-24   15:26 )
  Alkem Laboratories
 ( Results - Analysis 08-Nov-23   10:23 )
  Alkem Lab's Taloja facility clears UK MHRA inspection
 ( Hot Pursuit - 16-May-22   09:07 )
  Alkem Laboratories Ltd slips for fifth straight session
 ( Hot Pursuit - 22-May-23   13:35 )
  Alkem Laboratories Ltd down for fifth straight session
 ( Hot Pursuit - 04-Aug-22   13:35 )
  Alkem Laboratories Ltd spurts 1.48%
 ( Hot Pursuit - 15-Jul-22   13:05 )
Other Stories
  Aarti Industries allots 13,178 equity shares under ESOP
  04-Jul-24   20:31
  FSN E-Commerce Ventures announces incorporation of subsidiary in Qatar
  04-Jul-24   20:30
  Board of KDDL to consider proposal for buyback of shares
  04-Jul-24   20:28
  Aptech allots 821 equity shares under ESOP
  04-Jul-24   20:27
  InterGlobe Aviation allots 1.88 lakh equity shares under ESOS
  04-Jul-24   20:25
  H.G. Infra Engineering announces incorporation of step-down subsidiary
  04-Jul-24   20:21
  Raymond demerges its real estate biz into Raymond Realty
  04-Jul-24   20:15
  UTI AMD allots 13,512 equity shares under ESOS
  04-Jul-24   20:12
  DCB Bank announces change in senior management
  04-Jul-24   20:08
  Network 18 Media & Investments appoints director
  04-Jul-24   20:02
Back Top